跳至主要内容
临床试验/NCT05545865
NCT05545865招募中不适用

Preclinical Trials to Determine the Range of Chardonnay Mark Intake for Improved Metabolic and Vascular Response.

University of California, Davis1 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2022年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
5
试验地点
1
主要终点
Framingham Reactive Hyperemia Index (fRHI)

研究概览

简要总结

This study aims to obtain data on the potential influence of Vine to Bar product(s) containing Chardonnay marc on cardiometabolic health. These initial studies will inform the design and timing of data collection for future dietary intervention trials that will examine the influence of Chardonnay marc intake on outcomes/biomarkers of both cardiometabolic health and the gut microbiome. This includes collecting data on the potential differences in response to the products based on the unique food matrix for each of the products that will be tested. Moreover, as there is a paucity of data on the influence of cocoa flavanol intake on vascular function beyond 4 hours post intake, the response of the selected outcomes will be assessed after 6 hours of flavanol intake. This is a time point that captures the increased circulating presence of microbial derived flavanol metabolites.

详细描述

The current set of trials will be of an acute (single intake, followed over 6 hours) that examines the postprandial response of individuals to the products. These preclinical trials will be conducted in the same individuals in an crossover design in order to limit individual variability, and keep the numbers small (5 individuals maximum), but still be able to assess the response to the different products.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Double (Participant, Investigator)

盲法说明

Low and High flavanol cocoa will be provided in coded packaging.

入排标准

年龄范围
30 Years 至 50 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Screening or Visit 1 Reactive Hyperemia Index (RHI; EndoPAT 2000) < 2.0
  • Subject is willing and able to comply with the study protocols.
  • Subject is willing to participate in all study procedures
  • BMI 25.0 - 35 kg/m2

排除标准

  • BMI ≥ 35 kg/m2
  • Indivduals that weight less than a 110 lbs
  • Donation of blood within the previous 30 days
  • Visit 1 Reactive Hyperemia Index (RHI; EndoPAT 2000) ≥ 2.0
  • 1 ug/ml and 3 ug/ml collagen screening maximal platelet aggregatory response of < 65%.
  • Platelet counts < 150,000 / ul
  • Anemia, which includes self report, or a screening hemoglobin and hematocrit that is less than the normal reference range or as diagnosed by study physician upon review of complete blood cell count reports.
  • Dislike or allergy for nuts, cocoa or grape products
  • Self-reported use of daily anticoagulation agents including aspirin, NSAIDs
  • Vegan, Vegetarians, food faddists or those consuming a non-traditional diet
  • Fruit consumption ≥ 3 cups/day
  • Vegetable consumption ≥ 4 cups/day
  • Nut intake ≥ 2 servings/ week
  • Coffee/tea ≥ 3 cups/day
  • Dark chocolate ≥ 3 oz/day
  • Self-reported restriction of physical activity due to a chronic health condition
  • Self-reported chronic/routine high intensity exercise
  • Self-reported diabetes
  • Blood pressure ≥ 140/90 mm Hg
  • Self-reported renal or liver disease
  • Self-reported heart disease, which includes cardiovascular events and stroke
  • Peripheral artery disease, Raynaud's syndrome
  • Inability to properly place or wear the PAT probes or abnormal measurements on pre- screening PAT
  • Self-reported cancer within past 5 years
  • Self-reported malabsorption
  • Currently taking prescription drugs or supplements.
  • Supplement use or unwillingness to stop any supplement use, including herbal, plant or botanical, fish oil, oil supplements a month prior to study enrollment.
  • Indications of substance or alcohol abuse within the last 3 years
  • smoking, vaping, cannabis use
  • Current enrollee in a clinical research study.

研究组 & 干预措施

Low Flavanol Cocoa Powder

Placebo Comparator

12 g of Low Flavanol Cocoa Powder (30 mg of cocoa flavanols) provided as a beverage mixed in water

干预措施: High Flavanol Cocoa Powder (Other)

Low Flavanol Cocoa Powder

Placebo Comparator

12 g of Low Flavanol Cocoa Powder (30 mg of cocoa flavanols) provided as a beverage mixed in water

干预措施: Vine to Bar Chocolate - 2 servings (Other)

Low Flavanol Cocoa Powder

Placebo Comparator

12 g of Low Flavanol Cocoa Powder (30 mg of cocoa flavanols) provided as a beverage mixed in water

干预措施: Vine to Bar Chocolate - 1 serving (Other)

High Flavanol Cocoa Powder

Experimental

High Flavanol Cocoa Powder (435 mg of flavanols) will be provided as a beverage mixed in water.

干预措施: Low Flavanol Cocoa Powder (Other)

High Flavanol Cocoa Powder

Experimental

High Flavanol Cocoa Powder (435 mg of flavanols) will be provided as a beverage mixed in water.

干预措施: Vine to Bar Chocolate - 2 servings (Other)

High Flavanol Cocoa Powder

Experimental

High Flavanol Cocoa Powder (435 mg of flavanols) will be provided as a beverage mixed in water.

干预措施: Vine to Bar Chocolate - 1 serving (Other)

High Flavanol Cocoa Powder

Experimental

High Flavanol Cocoa Powder (435 mg of flavanols) will be provided as a beverage mixed in water.

干预措施: Vine to Bar Chocolate covered almonds (Other)

Two Servings of Vine to Bar Chocolate

Experimental

Two servings (60g, 6 pieces) of Vine to Bar Chocolate providing both cocoa flavanols and Chardonnay marc.

干预措施: Vine to Bar Chocolate - 1 serving (Other)

Two Servings of Vine to Bar Chocolate

Experimental

Two servings (60g, 6 pieces) of Vine to Bar Chocolate providing both cocoa flavanols and Chardonnay marc.

干预措施: Vine to Bar Chocolate covered almonds (Other)

One Serving of Vine to Bar Chocolate

Experimental

A single serving (30g, 3 pieces) of Vine to Bar Chocolate providing both cocoa flavanols and Chardonnay marc.

干预措施: Low Flavanol Cocoa Powder (Other)

One Serving of Vine to Bar Chocolate

Experimental

A single serving (30g, 3 pieces) of Vine to Bar Chocolate providing both cocoa flavanols and Chardonnay marc.

干预措施: High Flavanol Cocoa Powder (Other)

One Serving of Vine to Bar Chocolate

Experimental

A single serving (30g, 3 pieces) of Vine to Bar Chocolate providing both cocoa flavanols and Chardonnay marc.

干预措施: Vine to Bar Chocolate - 2 servings (Other)

One Serving of Vine to Bar Chocolate

Experimental

A single serving (30g, 3 pieces) of Vine to Bar Chocolate providing both cocoa flavanols and Chardonnay marc.

干预措施: Vine to Bar Chocolate covered almonds (Other)

Vine to Bar Chocolate covered Almonds

Experimental

11 pieces (45g) of Vine to Bar Chocolate providing both cocoa flavanols and Chardonnay marc, with almonds

干预措施: Vine to Bar Chocolate - 2 servings (Other)

Vine to Bar Chocolate covered Almonds

Experimental

11 pieces (45g) of Vine to Bar Chocolate providing both cocoa flavanols and Chardonnay marc, with almonds

干预措施: Vine to Bar Chocolate - 1 serving (Other)

结局指标

主要结局

Framingham Reactive Hyperemia Index (fRHI)

时间窗: 6 hours

measurement of microvascular function using peripheral arterial tonometry (EndoPAT2000)

次要结局

  • Platelet aggregation(6 hours)
  • Total nitrate(6 hours)
  • soluble NADPH oxidase(6 hours)
  • Insulin(6 hours)
  • Glucose(6 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验